XML 13 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Interim Statements of Changes in Shareholders’ Equity (Unaudited) - USD ($)
Share capital and share premium
Warrants
Share-based payment reserve
Accumulated other comprehensive income
Accumulated deficit
Total
Balance at Oct. 31, 2023 $ 17,131,223 $ 459,341 $ 2,182,221 $ (21,250) $ (18,768,063) $ 983,472
Balance (in Shares) at Oct. 31, 2023 607,337          
Net loss for the period         (4,369,934) (4,369,934)
Issuance of common shares, pre-funded warrants and warrants $ 1,459,815 1,459,815
Issuance of common shares, pre-funded warrants and warrants (in Shares) 1,500,000          
Exercise of warrants $ 4,594,808 4,594,808
Exercise of warrants (in Shares) 1,500,274          
Common shares for services $ 511,190 (511,190)
Common shares for services (in Shares) 306,838          
Share-based compensation $ 103,699 701,062 804,761
Share-based compensation (in Shares) 64,794          
Balance at Jul. 31, 2024 $ 23,800,735 459,341 2,372,093 (21,250) (23,137,997) 3,472,922
Balance (in Shares) at Jul. 31, 2024 3,979,243          
Balance at Oct. 31, 2024 $ 24,168,256 459,341 2,523,946 (21,250) (24,022,741) 3,107,552
Balance (in Shares) at Oct. 31, 2024 4,265,186          
Net loss for the period         (3,169,141) (3,169,141)
Exercise of warrants $ 437,007 437,007
Exercise of warrants (in Shares) 310,388          
Issuance of common shares upon vesting of restricted share units $ 964,836 (964,836)
Issuance of common shares upon vesting of restricted share units (in Shares) 803,867          
Share-based compensation 690,250 690,250
Balance at Jul. 31, 2025 $ 25,570,099 $ 459,341 $ 2,249,360 $ (21,250) $ (27,191,882) $ 1,065,668
Balance (in Shares) at Jul. 31, 2025 5,379,441